181 related articles for article (PubMed ID: 19224930)
1. Inflammatory biomarkers, physical activity, waist circumference, and risk of future coronary heart disease in healthy men and women.
Rana JS; Arsenault BJ; Després JP; Côté M; Talmud PJ; Ninio E; Wouter Jukema J; Wareham NJ; Kastelein JJ; Khaw KT; Boekholdt SM
Eur Heart J; 2011 Feb; 32(3):336-44. PubMed ID: 19224930
[TBL] [Abstract][Full Text] [Related]
2. Physical inactivity, abdominal obesity and risk of coronary heart disease in apparently healthy men and women.
Arsenault BJ; Rana JS; Lemieux I; Després JP; Kastelein JJ; Boekholdt SM; Wareham NJ; Khaw KT
Int J Obes (Lond); 2010 Feb; 34(2):340-7. PubMed ID: 19918249
[TBL] [Abstract][Full Text] [Related]
3. Coronary heart disease incidence in women by waist circumference within categories of body mass index.
Canoy D; Cairns BJ; Balkwill A; Wright FL; Green J; Reeves G; Beral V;
Eur J Prev Cardiol; 2013 Oct; 20(5):759-62. PubMed ID: 23723327
[TBL] [Abstract][Full Text] [Related]
4. Lipoprotein-associated phospholipase A2, high-sensitivity C-reactive protein, and risk for incident coronary heart disease in middle-aged men and women in the Atherosclerosis Risk in Communities (ARIC) study.
Ballantyne CM; Hoogeveen RC; Bang H; Coresh J; Folsom AR; Heiss G; Sharrett AR
Circulation; 2004 Feb; 109(7):837-42. PubMed ID: 14757686
[TBL] [Abstract][Full Text] [Related]
5. Visceral adiposity and risk of coronary heart disease in relatively lean Chinese adults.
Zhang X; Shu XO; Li H; Yang G; Xiang YB; Cai Q; Ji BT; Gao YT; Zheng W
Int J Cardiol; 2013 Oct; 168(3):2141-5. PubMed ID: 23453877
[TBL] [Abstract][Full Text] [Related]
6. Impact of abdominal obesity and systemic hypertension on risk of coronary heart disease in men and women: the EPIC-Norfolk Population Study.
Rhéaume C; Arsenault BJ; Després JP; Faha ; Boekholdt SM; Wareham NJ; Khaw KT; Chir M
J Hypertens; 2014 Nov; 32(11):2224-30; discussion 2230. PubMed ID: 25101651
[TBL] [Abstract][Full Text] [Related]
7. C-reactive protein and coronary heart disease in western Turkey.
Onat A; Sansoy V; Yildirim B; Keleş I; Uysal O; Hergenç G
Am J Cardiol; 2001 Sep; 88(6):601-7. PubMed ID: 11564380
[TBL] [Abstract][Full Text] [Related]
8. Serum levels of type II secretory phospholipase A2 and the risk of future coronary artery disease in apparently healthy men and women: the EPIC-Norfolk Prospective Population Study.
Boekholdt SM; Keller TT; Wareham NJ; Luben R; Bingham SA; Day NE; Sandhu MS; Jukema JW; Kastelein JJ; Hack CE; Khaw KT
Arterioscler Thromb Vasc Biol; 2005 Apr; 25(4):839-46. PubMed ID: 15692105
[TBL] [Abstract][Full Text] [Related]
9. Inflammatory biomarkers and the prediction of coronary events among people at intermediate risk: the EPIC-Norfolk prospective population study.
Rana JS; Cote M; Després JP; Sandhu MS; Talmud PJ; Ninio E; Wareham NJ; Kastelein JJ; Zwinderman AH; Khaw KT; Boekholdt SM
Heart; 2009 Oct; 95(20):1682-7. PubMed ID: 19587389
[TBL] [Abstract][Full Text] [Related]
10. Anthropometric assessment of abdominal obesity and coronary heart disease risk in men: the PRIME study.
Gruson E; Montaye M; Kee F; Wagner A; Bingham A; Ruidavets JB; Haas B; Evans A; Ferrières J; Ducimetière PP; Amouyel P; Dallongeville J
Heart; 2010 Jan; 96(2):136-40. PubMed ID: 19561364
[TBL] [Abstract][Full Text] [Related]
11. Beyond low-density lipoprotein cholesterol: respective contributions of non-high-density lipoprotein cholesterol levels, triglycerides, and the total cholesterol/high-density lipoprotein cholesterol ratio to coronary heart disease risk in apparently healthy men and women.
Arsenault BJ; Rana JS; Stroes ES; Després JP; Shah PK; Kastelein JJ; Wareham NJ; Boekholdt SM; Khaw KT
J Am Coll Cardiol; 2009 Dec; 55(1):35-41. PubMed ID: 20117361
[TBL] [Abstract][Full Text] [Related]
12. Circulating secretory phospholipase A2 activity and risk of incident coronary events in healthy men and women: the EPIC-Norfolk study.
Mallat Z; Benessiano J; Simon T; Ederhy S; Sebella-Arguelles C; Cohen A; Huart V; Wareham NJ; Luben R; Khaw KT; Tedgui A; Boekholdt SM
Arterioscler Thromb Vasc Biol; 2007 May; 27(5):1177-83. PubMed ID: 17303774
[TBL] [Abstract][Full Text] [Related]
13. Plasma adiponectin levels are associated with insulin resistance, but do not predict future risk of coronary heart disease in women.
Lawlor DA; Davey Smith G; Ebrahim S; Thompson C; Sattar N
J Clin Endocrinol Metab; 2005 Oct; 90(10):5677-83. PubMed ID: 16076942
[TBL] [Abstract][Full Text] [Related]
14. A cardiovascular disease risk factor in children with congenital heart disease: unmasking elevated waist circumference - a CHAMPS* study *CHAMPS: Children's Healthy-Heart Activity Monitoring Program in Saskatchewan.
Barbour-Tuck E; Boyes NG; Tomczak CR; Lahti DS; Baril CL; Pockett C; Runalls S; Kakadekar A; Pharis S; Bradley TJ; Wright KD; Erlandson MC
BMC Cardiovasc Disord; 2020 May; 20(1):231. PubMed ID: 32429858
[TBL] [Abstract][Full Text] [Related]
15. Distinction of hypertriglyceridemic waist phenotype from simple abdominal obesity: interaction with sex hormone-binding globulin levels to confer high coronary risk.
Karagöz A; Onat A; Aydın M; Can G; Şimşek B; Yüksel M
Postgrad Med; 2017 Mar; 129(2):288-295. PubMed ID: 27846754
[TBL] [Abstract][Full Text] [Related]
16. Association Between Sleep Time and Pro- and Anti-Inflammatory Biomarkers Is Mediated by Abdominal Obesity Among Adolescents.
De Moraes ACF; Medeiros-Oliveira VC; Burford K; Schaan BD; Bloch K; de Carvalho KMB; Cureau FV; Nascimento-Ferreira MV
J Phys Act Health; 2023 Oct; 20(10):926-933. PubMed ID: 37295784
[TBL] [Abstract][Full Text] [Related]
17. Lipoprotein-associated phospholipase A2 adds to risk prediction of incident coronary events by C-reactive protein in apparently healthy middle-aged men from the general population: results from the 14-year follow-up of a large cohort from southern Germany.
Koenig W; Khuseyinova N; Löwel H; Trischler G; Meisinger C
Circulation; 2004 Oct; 110(14):1903-8. PubMed ID: 15451783
[TBL] [Abstract][Full Text] [Related]
18. Cross-sectional study of complement C3 as a coronary risk factor among men and women.
Onat A; Uzunlar B; Hergenç G; Yazici M; Sari I; Uyarel H; Can G; Sansoy V
Clin Sci (Lond); 2005 Feb; 108(2):129-35. PubMed ID: 15487975
[TBL] [Abstract][Full Text] [Related]
19. Oxidation-specific biomarkers, lipoprotein(a), and risk of fatal and nonfatal coronary events.
Tsimikas S; Mallat Z; Talmud PJ; Kastelein JJ; Wareham NJ; Sandhu MS; Miller ER; Benessiano J; Tedgui A; Witztum JL; Khaw KT; Boekholdt SM
J Am Coll Cardiol; 2010 Sep; 56(12):946-55. PubMed ID: 20828647
[TBL] [Abstract][Full Text] [Related]
20. Lipoprotein-associated phospholipase A2, high-sensitivity C-reactive protein, and risk for incident ischemic stroke in middle-aged men and women in the Atherosclerosis Risk in Communities (ARIC) study.
Ballantyne CM; Hoogeveen RC; Bang H; Coresh J; Folsom AR; Chambless LE; Myerson M; Wu KK; Sharrett AR; Boerwinkle E
Arch Intern Med; 2005 Nov; 165(21):2479-84. PubMed ID: 16314544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
